| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.9 |
| mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |